Arteriosclerosis, Vol 8, 103-129, Copyright © 1988 by American Heart Association
ARTICLES |
DM Small
Department of Medicine, Housman Medical Research Center, Boston University School of Medicine, Massachusetts.
This review summarizes the evidence that the physical properties of lipids which accumulate in the intima play major roles in the progression and regression of lesions of atherosclerosis. All of the three major classes of lipids that accumulate in lesions (phospholipids, cholesterol, and cholesterol esters) are water insoluble. Phospholipids and cholesterol esters are almost mutually insoluble, but cholesterol, a crystalline solid at 37 degrees C, has considerable solubility in phospholipid bilayers and cholesterol esters. In normal infant intima, cholesterol is solubilized by phospholipid membranes. During fatty streak development, groups of cells are stimulated to take up more cholesterol than they excrete. The excess cholesterol is biochemically converted to cholesterol ester, which separates as droplets to form foam cells. Some fatty streaks then undergo a transition to an intermediate lesion containing excess cholesterol which is carried in cholesterol-supersaturated membranes and droplets. When nucleation of this excess cholesterol occurs, it precipitates as crystals; their formation coincides with the onset of necrosis and plaque formation. The hallmark of plaque is the presence of inert cholesterol crystals. They appear to form from hydrolysis of the older deposits of cholesterol esters in the base of intermediate lesions. Thus, the lipids in plaques are stratified, with recently deposited cholesterol esters present in the luminal part of the intima and older deposits in the deeper regions. When plasma cholesterol is lowered below about 150 mg/dl, lipids are mobilized from lesions and regression gradually occurs. Early in the regression process, cholesterol esters are reduced at least partly by hydrolysis to yield cholesterol, some of which may crystallize and inhibit rapid regression. After prolonged periods of low plasma cholesterol, cholesterol esters and foam cells disappear and crystalline cholesterol gradually dissolves, leading to true regression.
This article has been cited by other articles:
![]() |
G. L. Weibel, M. R. Joshi, E. T. Alexander, P. Zhu, I. A. Blair, and G. H. Rothblat Overexpression of Human 15(S)-Lipoxygenase-1 in RAW Macrophages Leads to Increased Cholesterol Mobilization and Reverse Cholesterol Transport Arterioscler Thromb Vasc Biol, June 1, 2009; 29(6): 837 - 842. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Weibel, E. T. Alexander, M. R. Joshi, D. J. Rader, S. Lund-Katz, M. C. Phillips, and G. H. Rothblat Wild-Type ApoA-I and the Milano Variant Have Similar Abilities to Stimulate Cellular Lipid Mobilization and Efflux Arterioscler Thromb Vasc Biol, September 1, 2007; 27(9): 2022 - 2029. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Qiao, I. Ronen, J. Viereck, F. L. Ruberg, and J. A. Hamilton Identification of Atherosclerotic Lipid Deposits by Diffusion-Weighted Imaging Arterioscler Thromb Vasc Biol, June 1, 2007; 27(6): 1440 - 1446. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tsimikas, M. Aikawa, F. J. Miller Jr, E. R. Miller, M. Torzewski, S. R. Lentz, C. Bergmark, D. D. Heistad, P. Libby, and J. L. Witztum Increased Plasma Oxidized Phospholipid:Apolipoprotein B-100 Ratio With Concomitant Depletion of Oxidized Phospholipids From Atherosclerotic Lesions After Dietary Lipid-Lowering: A Potential Biomarker of Early Atherosclerosis Regression Arterioscler Thromb Vasc Biol, January 1, 2007; 27(1): 175 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Rosengren, H. Peilot, M. Umaerus, A.-C. Jonsson-Rylander, L. Mattsson-Hulten, C. Hallberg, P. Cronet, M. Rodriguez-Lee, and E. Hurt-Camejo Secretory Phospholipase A2 Group V: Lesion Distribution, Activation by Arterial Proteoglycans, and Induction in Aorta by a Western Diet Arterioscler Thromb Vasc Biol, July 1, 2006; 26(7): 1579 - 1585. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Mason, M. F. Walter, C. A. Day, and R. F. Jacob Active Metabolite of Atorvastatin Inhibits Membrane Cholesterol Domain Formation by an Antioxidant Mechanism J. Biol. Chem., April 7, 2006; 281(14): 9337 - 9345. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. L. Ruberg, J. Viereck, A. Phinikaridou, Y. Qiao, J. Loscalzo, and J. A. Hamilton Identification of cholesteryl esters in human carotid atherosclerosis by ex vivo image-guided proton MRS J. Lipid Res., February 1, 2006; 47(2): 310 - 317. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Jacob and R. P. Mason Lipid Peroxidation Induces Cholesterol Domain Formation in Model Membranes J. Biol. Chem., November 25, 2005; 280(47): 39380 - 39387. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Q. Nhan, W. C. Liles, and S. M. Schwartz Role of Caspases in Death and Survival of the Plaque Macrophage Arterioscler Thromb Vasc Biol, May 1, 2005; 25(5): 895 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhou, S. Lhotak, B. A. Hilditch, and R. C. Austin Activation of the Unfolded Protein Response Occurs at All Stages of Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice Circulation, April 12, 2005; 111(14): 1814 - 1821. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, A. B. Castoreno, W. Stockinger, and A. Nohturfft Modulation of Endosomal Cholesteryl Ester Metabolism by Membrane Cholesterol J. Biol. Chem., March 25, 2005; 280(12): 11876 - 11886. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Spagnuolo, L. Cigliano, L. D. D'Andrea, C. Pedone, and P. Abrescia Assignment of the Binding Site for Haptoglobin on Apolipoprotein A-I J. Biol. Chem., January 14, 2005; 280(2): 1193 - 1198. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Trogan, Z. A. Fayad, V. V. Itskovich, J.-G. S. Aguinaldo, V. Mani, J. T. Fallon, I. Chereshnev, and E. A. Fisher Serial Studies of Mouse Atherosclerosis by In Vivo Magnetic Resonance Imaging Detect Lesion Regression After Correction of Dyslipidemia Arterioscler Thromb Vasc Biol, September 1, 2004; 24(9): 1714 - 1719. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Mason, M. F. Walter, and R. F. Jacob Effects of HMG-CoA Reductase Inhibitors on Endothelial Function: Role of Microdomains and Oxidative Stress Circulation, June 1, 2004; 109(21_suppl_1): II-34 - II-41. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wentworth Jr., J. Nieva, C. Takeuchi, R. Galve, A. D. Wentworth, R. B. Dilley, G. A. DeLaria, A. Saven, B. M. Babior, K. D. Janda, et al. Evidence for Ozone Formation in Human Atherosclerotic Arteries Science, November 7, 2003; 302(5647): 1053 - 1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Camejo Hydrolytic Enzymes Released From Resident Macrophages and Located in the Intima Extracellular Matrix as Agents That Modify Retained Apolipoprotein B Lipoproteins Arterioscler Thromb Vasc Biol, August 1, 2003; 23(8): 1312 - 1313. [Full Text] [PDF] |
||||
![]() |
R. P. Mason and R. F. Jacob Membrane Microdomains and Vascular Biology: Emerging Role in Atherogenesis Circulation, May 6, 2003; 107(17): 2270 - 2273. [Full Text] [PDF] |
||||
![]() |
A. L. McIntosh, A. M. Gallegos, B. P. Atshaves, S. M. Storey, D. Kannoju, and F. Schroeder Fluorescence and Multiphoton Imaging Resolve Unique Structural Forms of Sterol in Membranes of Living Cells J. Biol. Chem., February 14, 2003; 278(8): 6384 - 6403. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Malek, C.-M. Li, C. Guidry, N. E. Medeiros, and C. A. Curcio Apolipoprotein B in Cholesterol-Containing Drusen and Basal Deposits of Human Eyes with Age-Related Maculopathy Am. J. Pathol., February 1, 2003; 162(2): 413 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Atshaves, S. M. Storey, A. Petrescu, C. C. Greenberg, O. I. Lyuksyutova, R. Smith III, and F. Schroeder Expression of fatty acid binding proteins inhibits lipid accumulation and alters toxicity in L cell fibroblasts Am J Physiol Cell Physiol, September 1, 2002; 283(3): C688 - C703. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Choudhury, V. Fuster, J. J. Badimon, E. A. Fisher, and Z. A. Fayad MRI and Characterization of Atherosclerotic Plaque: Emerging Applications and Molecular Imaging Arterioscler Thromb Vasc Biol, July 1, 2002; 22(7): 1065 - 1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Rekhter How to evaluate plaque vulnerability in animal models of atherosclerosis? Cardiovasc Res, April 1, 2002; 54(1): 36 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Miyake, X. T. Duong-Polk, J. M. Taylor, E. Z. Du, L. W. Castellani, A. J. Lusis, and R. A. Davis Transgenic Expression of Cholesterol-7-{alpha}-Hydroxylase Prevents Atherosclerosis in C57BL/6J Mice Arterioscler Thromb Vasc Biol, January 1, 2002; 22(1): 121 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. X. Rong, J. Li, E. D. Reis, R. P. Choudhury, H. M. Dansky, V. I. Elmalem, J. T. Fallon, J. L. Breslow, and E. A. Fisher Elevating High-Density Lipoprotein Cholesterol in Apolipoprotein E-Deficient Mice Remodels Advanced Atherosclerotic Lesions by Decreasing Macrophage and Increasing Smooth Muscle Cell Content Circulation, November 13, 2001; 104(20): 2447 - 2452. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.F. Bentzon and E. Falk Coronary plaques calling for action -- why, where and how many? Eur. Heart J. Suppl., August 1, 2001; 3(suppl_I): I3 - I9. [Abstract] [PDF] |
||||
![]() |
R. Haimovici, D. L. Gantz, S. Rumelt, T. F. Freddo, and D. M. Small The Lipid Composition of Drusen, Bruch's Membrane, and Sclera by Hot Stage Polarizing Light Microscopy Invest. Ophthalmol. Vis. Sci., June 1, 2001; 42(7): 1592 - 1599. [Abstract] [Full Text] |
||||
![]() |
R. A. Davis and T. Y. Hui 2000 George Lyman Duff Memorial Lecture : Atherosclerosis Is a Liver Disease of the Heart Arterioscler Thromb Vasc Biol, June 1, 2001; 21(6): 887 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Curcio, C. L. Millican, T. Bailey, and H. S. Kruth Accumulation of Cholesterol with Age in Human Bruch's Membrane Invest. Ophthalmol. Vis. Sci., January 1, 2001; 42(1): 265 - 274. [Abstract] [Full Text] |
||||
![]() |
S. Peng, W. Guo, J. D. Morrisett, M. T. Johnstone, and J. A. Hamilton Quantification of Cholesteryl Esters in Human and Rabbit Atherosclerotic Plaques by Magic-Angle Spinning 13C-NMR Arterioscler Thromb Vasc Biol, December 1, 2000; 20(12): 2682 - 2688. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Koh Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability Cardiovasc Res, September 1, 2000; 47(4): 648 - 657. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fischer, D. E Gutstein, Z. A Fayad, and V. Fuster Predicting plaque rupture: enhancing diagnosis and clinical decision-making in coronary artery disease Vascular Medicine, August 1, 2000; 5(3): 163 - 172. [Abstract] [PDF] |
||||
![]() |
H. C. McGill Jr, C. A. McMahan, A. W. Zieske, G. D. Sloop, J. V. Walcott, D. A. Troxclair, G. T. Malcom, R. E. Tracy, M. C. Oalmann, J. P. Strong, et al. Associations of Coronary Heart Disease Risk Factors With the Intermediate Lesion of Atherosclerosis in Youth Arterioscler Thromb Vasc Biol, August 1, 2000; 20(8): 1998 - 2004. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pasterkamp, E. Falk, H. Woutman, and C. Borst Techniques characterizing the coronary atherosclerotic plaque: influence on clinical decision making? J. Am. Coll. Cardiol., July 1, 2000; 36(1): 13 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Guo, J. D. Morrisett, M. E. DeBakey, G. M. Lawrie, and J. A. Hamilton Quantification In Situ of Crystalline Cholesterol and Calcium Phosphate Hydroxyapatite in Human Atherosclerotic Plaques by Solid-State Magic Angle Spinning NMR Arterioscler Thromb Vasc Biol, June 1, 2000; 20(6): 1630 - 1636. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Romer, J. F. Brennan III, G. J. Puppels, A. H. Zwinderman, S. G. van Duinen, A. van der Laarse, A. F. W. van der Steen, N. A. Bom, and A. V. G. Bruschke Intravascular Ultrasound Combined With Raman Spectroscopy to Localize and Quantify Cholesterol and Calcium Salts in Atherosclerotic Coronary Arteries Arterioscler Thromb Vasc Biol, February 1, 2000; 20(2): 478 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. A. Bocan, B. R. Krause, W. S. Rosebury, S. B. Mueller, X. Lu, C. Dagle, T. Major, C. Lathia, and H. Lee The ACAT Inhibitor Avasimibe Reduces Macrophages and Matrix Metalloproteinase Expression in Atherosclerotic Lesions of Hypercholesterolemic Rabbits Arterioscler Thromb Vasc Biol, January 1, 2000; 20(1): 70 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kellner-Weibel, P. G. Yancey, W. G. Jerome, T. Walser, R. P. Mason, M. C. Phillips, and G. H. Rothblat Crystallization of Free Cholesterol in Model Macrophage Foam Cells Arterioscler Thromb Vasc Biol, August 1, 1999; 19(8): 1891 - 1898. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Zimmermann-Paul, H. H. Quick, P. Vogt, G. K. von Schulthess, D. Kling, and J. F. Debatin High-Resolution Intravascular Magnetic Resonance Imaging : Monitoring of Plaque Formation in Heritable Hyperlipidemic Rabbits Circulation, March 2, 1999; 99(8): 1054 - 1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chancharme, P. Therond, F. Nigon, S. Lepage, M. Couturier, and M. J. Chapman Cholesteryl Ester Hydroperoxide Lability Is a Key Feature of the Oxidative Susceptibility of Small, Dense LDL Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 810 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rabbani and E. J. Topol Strategies to achieve coronary arterial plaque stabilization Cardiovasc Res, February 1, 1999; 41(2): 402 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. M. Gronholdt Ultrasound and Lipoproteins as Predictors of Lipid-Rich, Rupture-Prone Plaques in the Carotid Artery Arterioscler Thromb Vasc Biol, January 1, 1999; 19(1): 2 - 13. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Fuster, J. J. Badimon, and J. H Chesebro Atherothrombosis: mechanisms and clinical therapeutic approaches Vascular Medicine, August 1, 1998; 3(3): 231 - 239. [Abstract] [PDF] |
||||
![]() |
R. S. Rosenson and C. C. Tangney Antiatherothrombotic Properties of Statins: Implications for Cardiovascular Event Reduction JAMA, May 27, 1998; 279(20): 1643 - 1650. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Romer, J. F. Brennan III, M. Fitzmaurice, M. L. Feldstein, G. Deinum, J. L. Myles, J. R. Kramer, R. S. Lees, and M. S. Feld Histopathology of Human Coronary Atherosclerosis by Quantifying Its Chemical Composition With Raman Spectroscopy Circulation, March 10, 1998; 97(9): 878 - 885. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kellner-Weibel, W. G. Jerome, D. M. Small, G. J. Warner, J. K. Stoltenborg, M. A. Kearney, M. H. Corjay, M. C. Phillips, and G. H. Rothblat Effects of Intracellular Free Cholesterol Accumulation on Macrophage Viability : A Model for Foam Cell Death Arterioscler Thromb Vasc Biol, March 1, 1998; 18(3): 423 - 431. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yuan, C. Petty, K. D. O'Brien, T. S. Hatsukami, J. F. Eary, and B. G. Brown In Vitro and In Situ Magnetic Resonance Imaging Signal Features of Atherosclerotic Plaque-Associated Lipids Arterioscler Thromb Vasc Biol, August 1, 1997; 17(8): 1496 - 1503. [Abstract] [Full Text] |
||||
![]() |
C. V. Felton, D. Crook, M. J. Davies, and M. F. Oliver Relation of Plaque Lipid Composition and Morphology to the Stability of Human Aortic Plaques Arterioscler Thromb Vasc Biol, July 1, 1997; 17(7): 1337 - 1345. [Abstract] [Full Text] |
||||
![]() |
J. F. Brennan III, T. J. Romer, R. S. Lees, A. M. Tercyak, J. R. Kramer Jr, and M. S. Feld Determination of Human Coronary Artery Composition by Raman Spectroscopy Circulation, July 1, 1997; 96(1): 99 - 105. [Abstract] [Full Text] |
||||
![]() |
J.-F. Toussaint, J. F. Southern, V. Fuster, and H. L. Kantor Water Diffusion Properties of Human Atherosclerosis and Thrombosis Measured by Pulse Field Gradient Nuclear Magnetic Resonance Arterioscler Thromb Vasc Biol, March 1, 1997; 17(3): 542 - 546. [Abstract] [Full Text] |
||||
![]() |
E. C. Tozer and T. E. Carew Residence Time of Low-Density Lipoprotein in the Normal and Atherosclerotic Rabbit Aorta Circ. Res., February 1, 1997; 80(2): 208 - 218. [Abstract] [Full Text] |
||||
![]() |
I. Tabas, S. Marathe, G. A. Keesler, N. Beatini, and Y. Shiratori Evidence That the Initial Up-regulation of Phosphatidylcholine Biosynthesis in Free Cholesterol-loaded Macrophages Is an Adaptive Response That Prevents Cholesterol-induced Cellular Necrosis. PROPOSED ROLE OF AN EVENTUAL FAILURE OF THIS RESPONSE IN FOAM CELL NECROSIS IN ADVANCED ATHEROSCLEROSIS J. Biol. Chem., September 13, 1996; 271(37): 22773 - 22781. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shiratori, M. Houweling, X. Zha, and I. Tabas Stimulation of CTP:Phosphocholine Cytidylyltransferase by Free Cholesterol Loading of Macrophages Involves Signaling through Protein Dephosphorylation J. Biol. Chem., December 15, 1995; 270(50): 29894 - 29903. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Falk, P. K. Shah, and V. Fuster Coronary Plaque Disruption Circulation, August 1, 1995; 92(3): 657 - 671. [Full Text] |
||||
![]() |
G. S. Retzinger Adsorption and Coagulability of Fibrinogen on Atheromatous Lipid Surfaces Arterioscler Thromb Vasc Biol, June 1, 1995; 15(6): 786 - 792. [Abstract] [Full Text] |
||||
![]() |
G. J. Warner, G. Stoudt, M. Bamberger, W. J. Johnson, and G. H. Rothblat Cell Toxicity Induced by Inhibition of Acyl Coenzyme A:Cholesterol Acyltransferase and Accumulation of Unesterified Cholesterol J. Biol. Chem., March 17, 1995; 270(11): 5772 - 5778. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Levine, J. F. Keaney, and J. A. Vita Cholesterol Reduction in Cardiovascular Disease -- Clinical Benefits and Possible Mechanisms N. Engl. J. Med., February 23, 1995; 332(8): 512 - 521. [Full Text] [PDF] |
||||
![]() |
D. Steinberg and J. L. Witztum Lipoproteins and Atherogenesis: Current Concepts JAMA, December 19, 1990; 264(23): 3047 - 3052. [Abstract] [PDF] |
||||
![]() |
D. H. Blankenhorn, R. L. Johnson, W. J. Mack, H. A. El Zein, and L. I. Vailas The Influence of Diet on the Appearance of New Lesions in Human Coronary Arteries JAMA, March 23, 1990; 263(12): 1646 - 1652. [Abstract] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1988 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |